Breaking News on Supplements & Nutrition - EuropeUS edition

On your radar > Financial plays

Financial plays

Digging below the bottom lines of ingredients suppliers and brand behemoths. From the impact of the ongoing economic slowdown to the latest in merger and acquisition activity.

Exclusive interview

BASF nutrition president on high-end omega-3, Equateq and the phood “white space”

BASF is moving en masse into omega-3 - especially if its bid for Norwegian player Pronova is approved - but it is technology gained from its May acquisition of a high-dose omega-3...

Evolva pays €550,000 for Fluxome resveratrol business

Swiss biotech firm Evolva has bought failing Fluxome’s, yeast-derived resveratrol business for about €550,000 in cash and shares, but says it has no interest in the remaining omega-3 business being...

Nestlé eyes herbal sector with Hong Kong JV; 2013 clinical trials planned

Nestlé has amplified its nutrition presence by forming a joint venture to develop Traditional Chinese Medicines (TCM). Orally consumed gastro products will be first off the rank based on an...

Reckitt Benckiser-Schiff: Another giant jumps into nutra space

UK-based consumer goods firm Reckitt Benckiser told NutraIngredients today, “nutrition had been on its radar for awhile”, as it plunged $1.4bn (€1.09bn) to outbid German pharma firm Bayer for the US’s second...

Asian specialist buys Swiss ingredients business

DKSH’s Performance Materials unit has paid undisclosed sum for Swiss ingredients and chemicals firm Staerkle & Nagler, as the Asian player moves to boost its European presence.

Fluxome finds a last-minute buyer: But is it resveratrol or omega-3 to be sold?

Swiss biotech firm Evolva has agreed to buy undisclosed assets from Fluxome, as it leaves its pure pharma research past in the dust and throws the embattled Danish supplier a...

BASF bids $823m for Pronova

BASF bids $823m for GSK omega-3 supplier Pronova Biopharma

BASF has made a bid for Pronova Biopharma ASA, underlining its intention to become the dominant player in the pharmaceutical grade omega-3 API market.  

Croatian functional foods and supplements maker wins €300m development loan

Croatian food company Atlantic Grupa has won a €307m finance package from the European Bank for Reconstruction and Development (EBRD) for new energy systems, sustainability certifications and working capital financing.

DSM buys Fortitech for €495m; “We are done for awhile”

Rampant nutrition business acquirer, Royal DSM, has splashed the cash for the ninth time in two years – this time to the tune of €495m ($634m) on US-based multinational nutrient...

Raisio sales rise 14%; Benecol steady

Ingredients, grain, snack brand and stanol-based cholesterol-lowering Benecol brand owner Raisio had a healthy Q3 with revenues up 14% to €160m from €141.7m in Q3 2011.

Bayer “absolutely open” to further acquisitions after $1.2bn Schiff shop

The consumer arm of German pharma giant Bayer Healthcare is to pay $1.2bn (€920m) for US food supplements company Schiff Nutrition International, a move that will make it one of...

Vitamin price drops but BASF nutrition sees 4% sales growth

BASF’s nutrition and health unit (N&H) earned €492m in Q3 – 4% more for the quarter than in 2011 when it had sales of €471m – despite falling prices for...

Nestlé 9-month sales up 11%

Emerging markets continue to drive Nestlé sales

Food and nutrition giant Nestlé has reported improved sales in its 9-month results driven by growth in emerging markets, but Q3 was a little slower than last year.

Aker BioMarine set to merge with seafoods branch after AXA pullout

Norwegian krill specialist Aker BioMarine is set to merge with Aker Seafoods Holding after winning board approval, a move prompted by the intended divestment of a major investor.

Frutarom president and chief executive Ori Yehudai: "The acquisitions have created many opportunities..."

Frutarom posts powerful profit and sales growth

Frutarom has posted strong double digit growth figures for its second quarter/half year results, driven by acquisitions, organic growth, price increases, falling raw material costs and more favourable purchasing deals....

Krill revenues up 23% at Aker Biomarine; Norwegians looking to expand

Krill specialist Aker BioMarine is looking at expanding production after its Q2 results showed operating revenue growth of 23% from NOK87m (€11.91m) in Q2 2011, to NOK107m (€14.65m) in Q2 2012.

Nestlé's Pure Life range was a star performer for Nestlé Waters

Nestlé first half results: Pros and cons

Europe and North America were the worst performing regions for Nestlé according to its first half (H1) results, while Asia, Oceania, Africa and emerging markets delivered double digit growth.

Nutrition shines as profits and sales slide at recession-hit DSM

Royal DSM paid tribute to its nutrition division which held steady as its sales and profits dipped for the second quarter and first half of the financial year, as recessed...

Provexis takes €5m yearly loss but bullish about sports supplement acquisition

The CEO of UK start-up Provexis is bullish about the company’s prospects to develop its Fruitflow tomato extract and the Science in Sport (SiS) sports supplement range it acquired a...

AAK posts high Q2 profits as ingredients volumes grow

AarhusKarlshamn (AAK) has recorded strong second quarter (Q2) results driven by volume growth in its ingredients segment.

‘Global brand’ stardust rubs off across Arla during 'strong' 2011

Arla Foods has announced a strong set of results for 2011, and the company has told DairyReporter.com that this is due in large part tighter ‘global brand’ focus that is...

Kerry Group 2011 revenue pegged at €5.3bn

Ingredients and flavours strong for Kerry within ‘stable, unsurprising’ results

Favourable consumer trends for healthy formulations and natural flavours ensured steady growth in the ingredients and flavours segment of Kerry Group.

Nestlé invests €50m in 5-year probiotic licensing deal

Swedish probiotics player BioGaia is welcoming a 5-year, €50.8m extension to a licensing deal with Nestlé for use of its Lactobacillus reuteri probiotic strain in infant nutrition products.

Danone and Mead Johnson to make united Pfizer nutrition bid?

Danone and Mead Johnson may make a joint bid for the €8bn infant nutrition-dominated Pfizer nutrition business that is up for sale, according to press reports.

Probi sales jump 17% in 2011 as supplements market shines

Swedish probiotics supplier Probi has turned in healthy annual figures with sales up 17% to SEK94.4m (€10.67m) in 2011 from SEK80.4 (€9.90m) in 2010.